Join leading experts for an in-depth discussion on the evolving management of aortic regurgitation, with a focus on contemporary surgical and transcatheter treatment strategies. This webinar will explore the latest advances in aortic valve repair, valve-sparing root replacement, and transcatheter therapies, highlighting patient selection, technical considerations, and emerging evidence. Gain practical insights into current challenges and future directions shaping the care of patients with aortic regurgitation.
The latest techniques and management strategies in cardiovascular and thoracic critical care and enhanced recovery after surgery for the entire care team.
A world-class, international event that will explore the latest developments and best practices in coronary artery disease, congenital heart disease, thoracic aortic disease, atrial fibrillation, and the surgical management of heart failure
The premier annual event in cardiothoracic surgery, unveiling never-before-seen science, techniques, and technology, and creating a forum to build lasting connections with colleagues.
STS is pleased to present a webinar on the Surgical Management of Thoracic Trauma, in collaboration with the Indian Society of Thoracic Surgeons and Trust, the Indian Association of Cardiovascular-Thoracic Surgeons, and ESTS Women in Thoracic Surgery. This expert-led session will feature internationally recognized faculty discussing contemporary approaches to thoracic trauma, including rib fixation, minimally invasive techniques, damage control strategies, and the management of complex thoracic injuries.
In his 2026 STS Annual Meeting presentation, Defining Success in Surgical Treatment of Afib: The Need for Standardization, Dr. Michael Bowdish discussed the development of a new quality measure for the treatment of preoperative atrial fibrillation and the evidence for long-term benefits to patients whose AFib is treated during cardiac surgery.
During this webinar, presenters will look at surgeon readiness for operating following neoadjuvant immunotherapy and targeted therapies, while sharing new knowledge of pathology review and standardized assessment of pathologic complete response (pCR). The program reinforces the rationale for adjuvant therapy continuation, drawing on evidence from AEGEAN, including event-free survival outcomes, pathology-linked insights, and postoperative treatment sequencing. The session also defines the surgeon’s role in educating patients across the full treatment journey.
